News|Articles|April 20, 2026

Applying Behavioral Science to Improve Clinical Trial Design and Execution

Behavioral science reveals how recruitment failures, site disengagement, and underrepresentation in clinical trials are rooted in early design decisions, and what sponsors can do to address them before they become costly problems.

Slow recruitment, high dropout, and persistent underrepresentation are among the most costly and enduring challenges in clinical research. Behavioral science offers a framework for addressing them not as isolated operational problems, but as predictable consequences of how trials are designed, sites are selected, and patients are engaged.

Related to this article

© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.